Tag Archives: NASDAQ:TEVA

Teva Pharmaceutical (NASDAQ:TEVA) Tumbles to Four Week Low – TEVA, WPI, NVS, PRX

Posted on May 29, 2012 by Thomas Vedder

Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) tumbled to a fourth week lowest level in New York and marked its biggest losing streak since November, as the company guidance lowers spurred Piper Jaffray & Co. to advocate investors keep away from …

Posted in Latest Headlines | Tagged NASDAQ:TEVA, Novartis, NVS, NYSE:NVS, NYSE:PRX, NYSE:WPI, Par Pharmaceutical, PRX, TEVA, Teva Pharmaceutical, Watson Pharmaceuticals, WPI | Comments Off

Healthcare Sectors Showed Positive Momentum- OREX, ARNA, VVUS, DVAX, TEVA, WCRX, AMRN, FRX, RDEA

Posted on May 14, 2012 by Thomas Vedder

Orexigen Therapeutics, Inc. (NASDAQ:OREX) diet-drug developer, jumped 20 percent to $4.03 on Friday in the wake of news that an advisory panel of the US Food and Drug Administration has suggested authorization of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) diet pill lorcaserin …

Posted in Healthcare, Latest Headlines | Tagged Amarin, AMRN, Ardea Biosciences, Arena Pharmaceuticals, ARNA, DVAX, Dynavax, Forest, FRX, NASDAQ:AMRN, NASDAQ:ARNA, NASDAQ:DVAX, NASDAQ:OREX, NASDAQ:RDEA, NASDAQ:TEVA, NASDAQ:VVUS, NASDAQ:WCRX, NYSE:FRX, OREX, Orexigen Therapeutics, RDEA, TEVA, Vivus, VVUS, Warner Chilcott, WCRX | Comments Off

Most Worse Momentum at Healthcare Sector, Shares Plunges More Than 20%- SGYP, ALXA, AMRN, WCRX, TEVA, RDEA, AGN

Posted on May 7, 2012 by Thomas Vedder

Shares of Synergy Pharmaceuticals (SGYP) go into the chasm, after the pharma’s reported that it plans to offer 10 million common stock shares to finance its research and development activities, which comprise clinical trials of its plecanatide and SP-333 treatments …

Posted in Healthcare, Latest Headlines | Tagged AGN, Alexza Pharmaceuticals, Allergan, ALXA, Amarin, AMRN, Ardea Biosciences, NASDAQ:ALXA, NASDAQ:AMRN, NASDAQ:RDEA, NASDAQ:SGYP, NASDAQ:TEVA, NASDAQ:WCRX, NYSE:AGN, RDEA, SGYP, Synergy Pharmaceuticals, TEVA, Teva Pharmaceutical, Warner Chilcott, WCRX | Comments Off

What’s up Teva Pharmaceuticals, Valeant Pharmaceuticals and Lions Gate Entertainment?

Posted on March 26, 2012 by Cameron White

In this report: Teva Pharmaceuticals (NASDAQ:TEVA), Valeant Pharmaceuticals International (NYSE:VRX) and Lions Gate Entertainment (NYSE:LGF)

Teva Pharmaceuticals (NASDAQ:TEVA) shares have jumped over 1.7 percent higher today after the company announced that the Food and Drug Administration has approved its Qnasl …

Posted in Latest Headlines, Reports | Tagged LGF, Lions Gate Entertainment, NASDAQ:TEVA, NYSE:LGF, NYSE:VRX, TEVA, Teva Pharmaceuticals, Valeant Pharmaceuticals International, VRX | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.